HIV antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir use different pathways to affect inflammation, senescence and insulin sensitivity in human coronary endothelial cells
出版年份 2020 全文链接
标题
HIV antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir use different pathways to affect inflammation, senescence and insulin sensitivity in human coronary endothelial cells
作者
关键词
Insulin, Inflammation, Endothelial cells, Antiretrovirals, Insulin resistance, Secretion, Insulin signaling, Tubulins
出版物
PLoS One
Volume 15, Issue 1, Pages e0226924
出版商
Public Library of Science (PLoS)
发表日期
2020-01-24
DOI
10.1371/journal.pone.0226924
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Maraviroc intensification modulates atherosclerotic progression in HIV suppressed patients at high cardiovascular risk. A randomized, cross-over, pilot study
- (2019) Daniela Francisci et al. Open Forum Infectious Diseases
- Metabolic complications affecting adipose tissue, lipid and glucose metabolism associated with HIV antiretroviral treatment
- (2019) Claire Lagathu et al. Expert Opinion On Drug Safety
- Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study
- (2019) Christine Katlama et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV
- (2019) Willem D.F. Venter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial
- (2019) Hans-Jürgen Stellbrink et al. Lancet HIV
- Immediate vs. Deferred Switching from a Boosted Protease Inhibitor (PI/r) Based Regimen to a Dolutegravir (DTG) Based Regimen in Virologically Suppressed Patients with High Cardiovascular Risk or Age ≥50 years: Final 96 Weeks Results of NEAT 022 study
- (2018) José M Gatell et al. CLINICAL INFECTIOUS DISEASES
- Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy
- (2018) Obiageli Offor et al. PLoS One
- Risks of cardiovascular or central nervous system adverse events and immune reconstitution inflammatory syndrome, for dolutegravir versus other antiretrovirals
- (2018) Andrew M. Hill et al. Current Opinion in HIV and AIDS
- Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study
- (2018) Lene Ryom et al. Lancet HIV
- USP18 - a multifunctional component in the Interferon response
- (2018) Anja Basters et al. BIOSCIENCE REPORTS
- Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients
- (2018) Leonardo Calza et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Exercise ameliorates insulin resistance via regulating TGFβ-activated kinase 1 (TAK1)-mediated insulin signaling in liver of high-fat diet-induced obese rats
- (2018) Yong Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity
- (2017) Shimin An et al. HEPATOLOGY
- The Fat of the Matter: Obesity and Visceral Adiposity in Treated HIV Infection
- (2017) Jordan E. Lake Current HIV/AIDS Reports
- Endothelial PPAR-γ provides vascular protection from IL-1β-induced oxidative stress
- (2016) Masashi Mukohda et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s
- (2016) Grace A. McComsey et al. CLINICAL INFECTIOUS DISEASES
- Cardiovascular Disease, Statins, and HIV
- (2016) Allison Ross Eckard et al. JOURNAL OF INFECTIOUS DISEASES
- The impact of insulin resistance on the kidney and vasculature
- (2016) Ferruh Artunc et al. Nature Reviews Nephrology
- Maraviroc Reduces Arterial Stiffness in PI-Treated HIV-infected Patients
- (2016) Stefania Piconi et al. Scientific Reports
- Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s
- (2016) Sahera Dirajlal-Fargo et al. Open Forum Infectious Diseases
- Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patients
- (2015) Pierre Duffau et al. AIDS
- Ten-year improvement of insulin resistance and growth with recombinant human insulin-like growth factor 1 in a patient with insulin receptor mutations resulting in leprechaunism
- (2015) M. de Kerdanet et al. DIABETES & METABOLISM
- Sirtuin function in aging heart and vessels
- (2015) Chiara Cencioni et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Cellular and molecular biology of aging endothelial cells
- (2015) Anthony J. Donato et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- USP18 negatively regulates NF-κB signaling by targeting TAK1 and NEMO for deubiquitination through distinct mechanisms
- (2015) Zhifen Yang et al. Scientific Reports
- The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction, excessive superoxide production, and inflammation with aging in mice
- (2014) Lindsey B. Gano et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Impact of darunavir, atazanavir and lopinavir boosted with ritonavir on cultured human endothelial cells: beneficial effect of pravastatin
- (2014) Martine Auclair et al. ANTIVIRAL THERAPY
- Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor
- (2014) E. X. Stavrou et al. BLOOD
- Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study
- (2014) J. Schouten et al. CLINICAL INFECTIOUS DISEASES
- The CCR5 chemokine receptor mediates vasoconstriction and stimulates intimal hyperplasia in human vessels in vitro
- (2013) J. J. Maguire et al. CARDIOVASCULAR RESEARCH
- USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1–TAB1 complex
- (2013) Xikui Liu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- HIV and Coronary Heart Disease
- (2013) Franck Boccara et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir
- (2012) Esteban Martínez et al. AIDS
- FOXOs and Sirtuins in Vascular Growth, Maintenance, and Aging
- (2012) Mark F. Oellerich et al. CIRCULATION RESEARCH
- Impact of Individual Antiretroviral Drugs on the Risk of Myocardial Infarction in Human Immunodeficiency Virus–Infected PatientsA Case-Control Study Nested Within the French Hospital Database on HIV ANRS Cohort CO4Antiretroviral Drugs, Risk of MI, and HIV
- (2010) Sylvie Lang ARCHIVES OF INTERNAL MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now